The Medical and Surgical Practice of NaProTECHNOLOGY, 509-540, 2004
Chapter 40: NaProTECHNOLOGY in Infertility
Author affiliations
- Pope Paul VI Institute for the Study of Human Reproduction, Omaha, Nebraska. ROR
Abstract
NaProTECHNOLOGY applies the standardized biomarkers of the Creighton Model FertilityCare System to identify the specific pathophysiological causes of infertility in each couple, then directs targeted medical or surgical intervention against those causes. Published pregnancy rates demonstrate outcomes comparable to or exceeding IVF in many diagnostic categories, without the ethical, financial, or obstetric risks associated with assisted reproduction.
Topics
Cite this article
Hilgers, T. W. (2004). Chapter 40: NaProTECHNOLOGY in Infertility. *The Medical and Surgical Practice of NaProTECHNOLOGY*, 509-540.
Hilgers TW. Chapter 40: NaProTECHNOLOGY in Infertility. The Medical and Surgical Practice of NaProTECHNOLOGY. 2004:509-540.
Hilgers, T. W. "Chapter 40: NaProTECHNOLOGY in Infertility." *The Medical and Surgical Practice of NaProTECHNOLOGY*, 2004, pp. 509-540.